Alibaba Health Information Technology Limited (ALBBY)
USD 8.67
(0.0%)
USD 8.67
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 27.02 Billion CNY | 0.98% |
| 2023 | 27.02 Billion CNY | 30.06% |
| 2022 | 20.57 Billion CNY | 32.6% |
| 2021 | 15.51 Billion CNY | 61.71% |
| 2020 | 9.59 Billion CNY | 88.32% |
| 2019 | 5.09 Billion CNY | 108.62% |
| 2018 | 2.44 Billion CNY | 414.15% |
| 2017 | 475.07 Million CNY | 739.43% |
| 2016 | 56.59 Million CNY | 90.15% |
| 2015 | 29.76 Million CNY | -38.2% |
| 2014 | 48.15 Million CNY | -87.73% |
| 2013 | 392.32 Million CNY | 0.26% |
| 2012 | 391.3 Million CNY | 24.63% |
| 2011 | 313.98 Million CNY | 24.02% |
| 2010 | 253.17 Million CNY | 4.54% |
| 2009 | 242.18 Million CNY | 15.17% |
| 2008 | 210.29 Million CNY | -25.62% |
| 2007 | 282.74 Million CNY | -32.21% |
| 2006 | 417.11 Million CNY | 57.81% |
| 2005 | 264.31 Million CNY | 51.8% |
| 2004 | 174.12 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 27.02 Billion CNY | 0.98% |
| 2024 Q2 | 1.81 Billion USD | 0.0% |
| 2024 Q4 | 1.95 Billion USD | 0.0% |
| 2023 Q2 | 1.7 Billion USD | 0.0% |
| 2023 FY | 26.76 Billion CNY | 30.06% |
| 2023 Q4 | 2.18 Billion USD | 0.0% |
| 2022 Q4 | 1.76 Billion USD | 0.0% |
| 2022 FY | 20.57 Billion CNY | 32.6% |
| 2022 Q2 | 1.44 Billion USD | 0.0% |
| 2021 Q2 | 1.02 Billion USD | 0.0% |
| 2021 Q4 | 1.27 Billion USD | 0.0% |
| 2021 FY | 15.51 Billion CNY | 61.71% |
| 2020 Q2 | 594.77 Million USD | 0.0% |
| 2020 FY | 9.59 Billion CNY | 88.32% |
| 2020 Q4 | 781.42 Million USD | 0.0% |
| 2019 FY | 5.09 Billion CNY | 108.62% |
| 2018 FY | 2.44 Billion CNY | 414.15% |
| 2017 FY | 475.07 Million CNY | 739.43% |
| 2016 FY | 56.59 Million CNY | 90.15% |
| 2015 FY | 29.76 Million CNY | -38.2% |
| 2014 FY | 48.15 Million CNY | -87.73% |
| 2013 FY | 392.32 Million CNY | 0.26% |
| 2012 FY | 391.3 Million CNY | 24.63% |
| 2011 FY | 313.98 Million CNY | 24.02% |
| 2010 FY | 253.17 Million CNY | 4.54% |
| 2009 FY | 242.18 Million CNY | 15.17% |
| 2008 FY | 210.29 Million CNY | -25.62% |
| 2007 FY | 282.74 Million CNY | -32.21% |
| 2006 FY | 417.11 Million CNY | 57.81% |
| 2005 FY | 264.31 Million CNY | 51.8% |
| 2004 FY | 174.12 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -13742.826% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -60658759.836% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | -133145.118% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -20481.625% |
| MedGen, Inc. | 1.05 USD | -2573957618947.619% |
| Omni Health, Inc. | 4.69 Million USD | -575509.675% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | -44184762.753% |
| Pineapple, Inc. | 381.89 Thousand USD | -7076952.293% |
| ScripsAmerica, Inc. | 30.85 Million USD | -87493.117% |